日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

晚期肝细胞癌患者在接受阿特珠单抗联合贝伐珠单抗治疗后,再接受纳武利尤单抗联合伊匹木单抗治疗的疗效:一项国际多中心研究

Kim, Jung Sun; Wong, Jeffrey; Chen, San-Chi; Tai, David; Yang, Hannah; Kim, Youngun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; An, Chansik; Jang, Su Jin; Kudo, Masatoshi; Lim, Ho Yeong; Kim, Chan; Yau, Thomas; Chon, Hong Jae

Organ-Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study

晚期肝细胞癌患者接受纳武利尤单抗联合伊匹木单抗治疗后器官特异性反应:一项多中心回顾性研究

Kim, Jung Sun; Kim, Youngun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; Lee, Won Suk; Hong, Jung Yong; Lim, Ho Yeong; Kim, Han Sang; Kim, Chang Gon; Jung, Sanghoon; An, Chansik; Kim, Chan; Chon, Hong Jae

Epidemiology and genomic features of biliary tract cancer and its unique features in Korea

韩国胆道癌的流行病学和基因组特征及其独特性

Woo, Seonjeong; Kim, Youngun; Hwang, Sohyun; Chon, Hong Jae

Distinct Characteristics and Changes in Liver Function of Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab for More Than 1 Year

接受阿特珠单抗联合贝伐珠单抗治疗超过1年的肝细胞癌患者的独特特征和肝功能变化

Kim, Youngun; Kim, Jung Sun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; Lee, Won Suk; Sang, Yun Beom; Jung, Sanghoon; An, Chansik; Kim, Chan; Chon, Hong Jae

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma

晚期肾细胞癌患者基线血清IL-10水平升高与一线免疫检查点抑制剂治疗的临床获益降低相关。

Kim, Youngun; Yang, Hannah; Lee, Won Suk; Cheon, Jaekyung; Sang, Yun Beom; Kang, Beodeul; Chon, Hong Jae; Kim, Chan

A Study on Trauma Mechanisms and Injury Sites in Patients with Blunt Abdominal Trauma

钝性腹部创伤患者的创伤机制和损伤部位研究

Choi, YoungUn; Kim, SuHyun; Ko, JiWool; Kim, MyoungJun; Shim, Hongjin; Han, JaeHun; Lim, JiHye; Kim, Kwangmin

PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

在 TGFβ 抑制剂存在的情况下,PD-1 阻断可重新激活多发性骨髓瘤患者的骨髓 CD8+ T 细胞

Minsuk Kwon #, Chang Gon Kim #, Hoyoung Lee #, Hyunsoo Cho, Youngun Kim, Eung Chang Lee, Seong Jin Choi, Junsik Park, In-Ho Seo, Bjarne Bogen, Ik-Chan Song, Deog-Yeon Jo, Jin Seok Kim, Su-Hyung Park, Inhak Choi, Yoon Seok Choi, Eui-Cheol Shin

VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers

VEGF-A 驱动抗 PD-1 耐药微卫星稳定型结直肠癌中 TOX 依赖性 T 细胞耗竭

Chang Gon Kim, Mi Jang, Youngun Kim, Galam Leem, Kyung Hwan Kim, Hoyoung Lee, Tae-Shin Kim, Seong Jin Choi, Hyung-Don Kim, Ji Won Han, Minsuk Kwon, Jong Hoon Kim, Andrew J Lee, Su Kyung Nam, Seok-Joo Bae, Sat Byol Lee, Sang Joon Shin, Sung Ho Park, Joong Bae Ahn, Inkyung Jung, Kang Young Lee, Su-Hyu